Building the clinical workflow layer for long-duration EEG
NerveDX is an Iceland-based enterprise neuroinformatics company building the regulated workflow layer for long-duration clinical EEG: faster review, structured documentation, governed AI triage, and operational evidence for hospitals and partners.
Make expert EEG capacity go further
Continuous and long-duration EEG produce hours of data that must be reviewed by highly trained clinicians. NerveDX exists to help services prioritise attention, document findings consistently, shorten turnaround, and preserve the clinical accountability required for regulated care.
Our core project is product and workflow engineering around the complete lifecycle, not a stand-alone algorithm. AI triage is governed inside a platform that also handles review, human confirmation, reporting, integration, quality evidence, and audit.
Clinically useful, commercially credible
We connect EEG expertise, software engineering, quality management, and pilot measurement into a pathway that can support hospital adoption, partner validation, and commercial diligence.
A platform case for clinicians, partners and commercial teams
NerveDX is positioned around a clear health-system problem: scarce reviewer time, growing EEG volumes, and a need for governed AI that fits regulated clinical operations.
For clinicians
Prioritised review, qEEG navigation, structured reporting, and transparent model outputs designed to keep expert judgment in control.
For partners
Measurable collaboration milestones: prototype validation, pilot KPIs, regulatory readiness, integration planning, and clinical workflow evidence.
For commercial teams
A workflow platform with enterprise data architecture, defensible clinical evidence, and expansion paths across EEG settings.
Our principles
Workflow-centric
We build the process around the EEG, not a single detection step. Review, navigation, confirmation, reporting, integration and audit hang together.
Regulated from the start
Quality management, security and compliance are embedded in the architecture — so commercialisation isn't a redesign but a continuation.
Human judgment wins
AI augments attention. Clinicians confirm, correct and sign off. Provenance and documentation keep every decision accountable.
Complementary, not duplicative
Where research communities have strong EEG/AI expertise, we see partners. Our focus is the broader clinical workflow and commercialisation layer.
Enterprise-grade
Multi-tenant, secure, auditable and integration-ready — built to operate inside hospital infrastructure and regulated environments.
Measure the ROI
We validate reviewer time saved, turnaround, triage accuracy, report consistency and workflow efficiency with pilot KPIs — not just feature checklists.
What we intend to prove
NerveDX should be judged by whether it makes long-duration EEG services easier to operate safely. The project is therefore framed around practical evidence rather than broad AI claims.
- Reviewer time saved without removing clinical sign-off
- Shorter time from recording to actionable report
- More consistent annotations and reporting language
- Auditable provenance for every model output and human decision
- Deployment readiness for privacy-conscious hospital environments
Why this is credible
The work combines clinical need, software innovation, regulated product development and practical health-system value.
- Clear prototype-to-pilot milestones
- Measurable healthcare productivity outcomes
- Alignment with quality and regulatory pathways
- Partner-friendly architecture for research and clinical validation
“The opportunity is not only to detect events in EEG. It is to turn long-duration EEG into a measurable, auditable clinical workflow that hospitals can adopt and scale.”NerveDX — Core Project
Let's talk
Whether you're an EEG service, a research partner or a commercial collaborator, we'd love to connect.